Today: 4 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Ciena (CIEN) Stock Soars to Record Highs Ahead of Q4 2025 Earnings: Is the AI Network Boom Already Priced In?

Ciena (CIEN) Stock Soars to Record Highs Ahead of Q4 2025 Earnings: Is the AI Network Boom Already Priced In?

Ciena shares hit a new 52-week high above $214 on December 9, trading near $216–217, up nearly 190% over the past year. The company’s market cap is close to $30 billion, with a trailing P/E near 200. Multiple analysts raised price targets ahead of fiscal Q4 results due December 11. The latest targets range up to $240, though consensus lags at $141 due to older estimates.
9 December 2025
··
BitMine Immersion Technologies (BMNR) Stock on December 9, 2025: Ethereum Mega-Treasury, New CEO and High-Risk 2026 Outlook

BitMine Immersion Technologies (BMNR) Stock on December 9, 2025: Ethereum Mega-Treasury, New CEO and High-Risk 2026 Outlook

BitMine Immersion Technologies (BMNR) holds 3,864,951 ETH, over 3% of the Ethereum supply, and reported $13.2 billion in crypto and cash as of December 7, 2025. Shares traded near $38.88 intraday on December 9, up 440% over the past year, with daily volume around $1.8 billion. The company is shifting from mining to ETH treasury management and services. BMNR’s 1-year beta is 15.9, reflecting extreme volatility.
9 December 2025
CRH plc Stock Surges Toward S&P 500 Debut – Latest News, Forecasts and Investment Outlook (December 9, 2025)

CRH plc Stock Surges Toward S&P 500 Debut – Latest News, Forecasts and Investment Outlook (December 9, 2025)

CRH shares traded at $125.49 on December 9, just below yesterday’s record $126.96, after news it will join the S&P 500 on December 22. The stock has surged nearly 40% in 2025, outpacing the market, and recently cleared a technical buy point. CRH is also conducting share buybacks and reporting double-digit earnings growth. Analyst sentiment remains positive, though some warn on valuation.
9 December 2025
·
Gold Price Above $4,200 as Fed Rate Cut Looms: Silver Hits Record, Oil Slips and Dollar Steadies on December 9, 2025

Gold Price Above $4,200 as Fed Rate Cut Looms: Silver Hits Record, Oil Slips and Dollar Steadies on December 9, 2025

Gold traded above $4,200 an ounce in New York Tuesday, up 60% in 2025 and on pace for its best year since 1979. Spot silver jumped over 4% to a record $60.52 an ounce. Traders are positioning ahead of the US Federal Reserve’s expected quarter-point rate cut at its December 9–10 meeting. Markets now see two more Fed cuts by end-2026, down from three last week.
9 December 2025
···
Beta Technologies (BETA) Stock on December 9, 2025: Price Action, $1B Eve Deal, Q3 Earnings and 2026–2030 Forecasts

Beta Technologies (BETA) Stock on December 9, 2025: Price Action, $1B Eve Deal, Q3 Earnings and 2026–2030 Forecasts

Beta Technologies (NYSE: BETA) traded at $30.46 midday Dec. 9, up 0.5%, with a market cap near $7.0 billion. The stock surged 8.8% Monday after its first public earnings, a $1 billion supply deal with Eve Air Mobility, and positive analyst reports. Beta’s Q3 revenue reached $8.9 million, but net loss widened to $452 million as spending rose. Shares remain about 10% below the $34 IPO price.
9 December 2025
··
Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx shares closed at $72.08 on December 9, down 2.7% after surging 13.6% pre-market on positive Phase 2 data for its multiple myeloma therapy anito-cel at ASH 2025. The iMMagine-1 study showed a 96% overall response rate and no delayed neurotoxicities in 117 heavily pretreated patients. Analysts maintain a “Strong Buy” consensus and anticipate a 2026 commercial launch.
9 December 2025
··
Cinemark Stock Reels From Netflix–Warner Shock, But Wall Street Still Sees Upside

Cinemark Stock Reels From Netflix–Warner Shock, But Wall Street Still Sees Upside

Cinemark shares traded near $23.75 intraday December 9, rebounding slightly after hitting a 52-week low of $23.12. The stock has dropped about 28% over the past year, with a steep 20% slide in early December following Netflix’s $80 billion deal to acquire Warner Bros. Discovery. Most analysts still rate Cinemark a Buy, citing potential upside despite ongoing volatility.
9 December 2025
···
Primoris Services (PRIM) Stock Today: JP Morgan Downgrade, Hedge Fund Buying And Growth Outlook – December 9, 2025

Primoris Services (PRIM) Stock Today: JP Morgan Downgrade, Hedge Fund Buying And Growth Outlook – December 9, 2025

Primoris Services shares have climbed over 70% year to date, trading near $132–133 as of mid-session December 9, 2025, with a market cap around $7.1 billion. JP Morgan downgraded the stock from “Overweight” to “Neutral” on December 8, citing valuation concerns after a strong run. Voya Investment Management reported strong Q3 gains from its overweight position in Primoris.
9 December 2025
·
Unity Software Stock (NYSE: U) Hits New Highs on Analyst Upgrades and AI Momentum – Is the Rally Sustainable?

Unity Software Stock (NYSE: U) Hits New Highs on Analyst Upgrades and AI Momentum – Is the Rally Sustainable?

Unity Software shares hit a new 12-month high near $48.9 on December 9, 2025, after stronger-than-expected Q3 results and multiple analyst upgrades. The stock has gained about 92% year-to-date. Q3 revenue rose 5% to $471 million, with adjusted EBITDA at $109 million. Investor focus remains on AI-driven products and recent insider selling.
9 December 2025
···
Bank of Canada Set to Hold Interest Rate at 2.25% on December 10, 2025 as Markets Bet on Long Pause

Bank of Canada Set to Hold Interest Rate at 2.25% on December 10, 2025 as Markets Bet on Long Pause

The Bank of Canada is expected to hold its overnight rate at 2.25% on December 10, following a series of aggressive cuts since mid-2024. All 33 economists in a recent Reuters poll forecast no change, with most anticipating the rate will stay at this level until at least 2027. The decision will be announced at 9:45 am Eastern, followed by a press conference.
9 December 2025
·
IMAX Stock Soars on Analyst Upgrades and China Growth: What December 2025’s Rally Really Means

IMAX Stock Soars on Analyst Upgrades and China Growth: What December 2025’s Rally Really Means

IMAX shares closed at $38.50 on December 8, up 7.8% after new analyst upgrades and news of a deepened China partnership. The stock sits near a 52-week high, up over 30% in six months, outpacing the broader market. Consensus analyst price targets now range from $32 to $47, with most ratings at “Buy.” Management issued bullish three-year growth guidance at its recent Investor Day.
9 December 2025
··
Praxis Precision Medicines (PRAX) Soars on FDA Momentum and 760-Dollar Target: December 9, 2025 Stock Deep Dive

Praxis Precision Medicines (PRAX) Soars on FDA Momentum and 760-Dollar Target: December 9, 2025 Stock Deep Dive

Praxis Precision Medicines shares traded near $265 on December 9, 2025, up over 500% in three months and close to a 52-week high of $278, giving the company a $6.6 billion market cap. The surge followed positive Phase 3 results for ulixacaltamide in essential tremor, new bullish analyst targets, and increased volatility after a short-seller attack.
9 December 2025
·
Avaada Group, GRIDCO and IIT Bhubaneswar to Set Up Green Hydrogen Center of Excellence in Odisha

Avaada Group, GRIDCO and IIT Bhubaneswar to Set Up Green Hydrogen Center of Excellence in Odisha

Avaada Group, GRIDCO, and IIT Bhubaneswar signed an agreement to establish a Green Hydrogen Center of Excellence in Odisha. The center will focus on research, technology development, and real-world deployment of green hydrogen. Avaada will host an extension facility within its Odisha complex and co-fund selected projects. The initiative is part of India’s National Green Hydrogen Mission.
9 December 2025
Arrowhead Pharmaceuticals (ARWR) Stock Soars on First FDA Approval, Novartis Deal and New Alzheimer’s Trial

Arrowhead Pharmaceuticals (ARWR) Stock Soars on First FDA Approval, Novartis Deal and New Alzheimer’s Trial

Arrowhead Pharmaceuticals stock surged to a 52-week high of $71.5 on December 8, 2025, after securing its first FDA approval for REDEMPLO and announcing a major Novartis licensing deal. Shares traded around $69 on December 9, up over 260% year-to-date, with market value near $9.5 billion. Trading volume more than doubled typical levels. The company also began dosing in an Alzheimer’s trial.
9 December 2025
··
Carvana Stock (CVNA) Soars on S&P 500 Inclusion: Latest Price, News, Analyst Forecasts and Risks as of December 9, 2025

Carvana Stock (CVNA) Soars on S&P 500 Inclusion: Latest Price, News, Analyst Forecasts and Risks as of December 9, 2025

Carvana shares traded near $450 on December 9, 2025, after S&P Dow Jones Indices announced the company will join the S&P 500 on December 22. The stock has surged about 120% in 2025 and over 8,000% since late 2022, pushing Carvana’s market value above Ford and GM. Recent earnings showed record Q3 results and strong guidance for Q4.
9 December 2025
··
1 … 497 498 499 500 501 … 584
Go toTop